Baader Bank set a €80.00 ($93.02) price target on Symrise (FRA:SY1) in a research report released on Thursday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
Other equities research analysts have also issued research reports about the stock. UBS Group set a €89.00 ($103.49) price objective on shares of Symrise and gave the stock a neutral rating in a research report on Thursday, July 11th. JPMorgan Chase & Co. set a €63.00 ($73.26) price target on shares of Symrise and gave the company a sell rating in a report on Tuesday, July 16th. Independent Research set a €85.00 ($98.84) price target on shares of Symrise and gave the company a neutral rating in a report on Wednesday, May 8th. Credit Suisse Group set a €87.00 ($101.16) price target on shares of Symrise and gave the company a buy rating in a report on Tuesday, April 30th. Finally, Goldman Sachs Group set a €77.50 ($90.12) price objective on shares of Symrise and gave the stock a neutral rating in a report on Tuesday, April 30th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and six have assigned a buy rating to the company’s stock. The company has an average rating of Hold and an average target price of €79.50 ($92.44).
Shares of Symrise stock traded down €1.08 ($1.26) during trading hours on Thursday, hitting €83.18 ($96.72). The company’s stock had a trading volume of 255,562 shares. Symrise has a 1-year low of €56.96 ($66.23) and a 1-year high of €73.48 ($85.44). The firm has a fifty day moving average price of €84.77.
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Recommended Story: Resistance Level
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.